ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009

Cancer “Report Card”: Growing Population Of Cancer Survivors Creates Need For New Research Emphasis, NCI Director Says

March 20, 1998

NCI Advisory Group, Other Cancer Meetings

February 28, 1986

First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive

November 27, 1987

Working Group to Look At Guidelines, Mandates, Centers Role In Prevention, Cancer Control

February 17, 1984